UMIN ID: UMIN000001979
Registered date:18/05/2009
Phase II study of a combined Paclitaxel, Gemcitabine, and Cisplatin chemotherapy regimen for advanced urothelial carcinoma
Basic Information
| Recruitment status | |
|---|---|
| Health condition(s) or Problem(s) studied | advanced urothelial carcinoma |
| Date of first enrollment | 2009/04/01 |
| Target sample size | 30 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Paclitaxel 80mg/m2; day 1, 8 Gemcitabine 1000mg/m2; day 1, 8 Cisplatin 50mg/m2; day 2 |
Outcome(s)
| Primary Outcome | response rate |
|---|---|
| Secondary Outcome | 1) safety 2)progression-free survival |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | 75years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | no other active malignancy Acute myocardial infarction within 3 months of this study |
Related Information
| Primary Sponsor | Cancer Institute Hospital, Japanese Foundation for Cancer Research |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Cancer Institute Hospital, Japanese Foundation for Cancer Research |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Yamamoto Shinya |
| Address | 3-10-6, Ariake, Koto-ku, Tokyo Japan |
| Telephone | 03-3520-0111 |
| shinya.yamamoto@jfcr.or.jp | |
| Affiliation | Cancer Institute Hospital, Japanese Foundation for Cancer Research Urology |
| scientific contact | |
| Name | Fukui Iwao |
| Address | 3-10-6, Ariake, Koto-ku, Tokyo Japan |
| Telephone | 03-3520-0111 |
| ifukui@jfcr.or.jp | |
| Affiliation | Cancer Institute Hospital, Japanese Foundation for Cancer Research Urology |